Publikationsserver
Dimethyl fumarate suppresses Tc17 cell fate in autoimmunity via ROS accumulation
Dimethyl fumarate (DMF) is approved for treatment of relapsing remitting multiple sclerosis (RRMS), a chronic inflammatory disease of the central nervous system (CNS) that is caused by autoreactive T cells. The effect mechanism of DMF is not fully elucidated so far; however, a preferential impact on...
Sábháilte in:
| Príomhchruthaitheoir: | |
|---|---|
| Rannpháirtithe: | |
| Formáid: | Dissertation |
| Teanga: | Béarla |
| Foilsithe / Cruthaithe: |
Philipps-Universität Marburg
2018
|
| Ábhair: | |
| Rochtain ar líne: | An téacs iomlán mar PDF |
| Clibeanna: |
Cuir clib leis
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|
Ar líne
An téacs iomlán mar PDF| Gairmuimhir: |
urn:nbn:de:hebis:04-z2018-03301 |
|---|---|
| Dáta a fhoilsithe: |
2019-02-28 |
| Datum der Annahme: |
2018-08-15 |
| Downloads: |
45 (2024), 86 (2023), 69 (2022), 72 (2021), 76 (2020), 69 (2019) |
| Lizenz: |
https://creativecommons.org/licenses/by-nc-sa/4.0 |
| URL Rochtana: |
https://archiv.ub.uni-marburg.de/diss/z2018/0330 https://doi.org/10.17192/z2018.0330 |